1014 related articles for article (PubMed ID: 30001569)
1. The pharmacokinetics and the pharmacodynamics of cannabinoids.
Lucas CJ; Galettis P; Schneider J
Br J Clin Pharmacol; 2018 Nov; 84(11):2477-2482. PubMed ID: 30001569
[TBL] [Abstract][Full Text] [Related]
2. Cannabis sativa: Much more beyond Δ
Alves P; Amaral C; Teixeira N; Correia-da-Silva G
Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.
Arellano AL; Papaseit E; Romaguera A; Torrens M; Farré M
CNS Neurol Disord Drug Targets; 2017; 16(5):554-566. PubMed ID: 28412920
[TBL] [Abstract][Full Text] [Related]
4. Cannabis, from plant to pill.
Grof CPL
Br J Clin Pharmacol; 2018 Nov; 84(11):2463-2467. PubMed ID: 29701252
[TBL] [Abstract][Full Text] [Related]
5. Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling.
Liu Z; Martin JH
Br J Clin Pharmacol; 2018 Nov; 84(11):2483-2487. PubMed ID: 29766540
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.
Anderson GD; Chan LN
Clin Pharmacokinet; 2016 Nov; 55(11):1353-1368. PubMed ID: 27106177
[TBL] [Abstract][Full Text] [Related]
7. Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450.
Bansal S; Maharao N; Paine MF; Unadkat JD
Drug Metab Dispos; 2020 Oct; 48(10):1008-1017. PubMed ID: 32587099
[TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
9. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
[TBL] [Abstract][Full Text] [Related]
10. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models.
Qian Y; Markowitz JS
Drug Metab Dispos; 2022 Jul; 50(7):968-979. PubMed ID: 35512806
[TBL] [Abstract][Full Text] [Related]
12. The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications.
Qian Y; Gurley BJ; Markowitz JS
J Clin Psychopharmacol; 2019; 39(5):462-471. PubMed ID: 31433338
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of cannabinoids.
Grotenhermen F
Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025
[TBL] [Abstract][Full Text] [Related]
14. Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice.
Iannotti FA; Pagano E; Moriello AS; Alvino FG; Sorrentino NC; D'Orsi L; Gazzerro E; Capasso R; De Leonibus E; De Petrocellis L; Di Marzo V
Br J Pharmacol; 2019 May; 176(10):1568-1584. PubMed ID: 30074247
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid-induced alterations in brain disposition of drugs of abuse.
Reid MJ; Bornheim LM
Biochem Pharmacol; 2001 Jun; 61(11):1357-67. PubMed ID: 11331071
[TBL] [Abstract][Full Text] [Related]
17. Promoting cannabis products to pharmaceutical drugs.
Koltai H; Poulin P; Namdar D
Eur J Pharm Sci; 2019 Apr; 132():118-120. PubMed ID: 30851400
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
Nahler G
Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
[TBL] [Abstract][Full Text] [Related]
19. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material.
De Backer B; Debrus B; Lebrun P; Theunis L; Dubois N; Decock L; Verstraete A; Hubert P; Charlier C
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(32):4115-24. PubMed ID: 19932642
[TBL] [Abstract][Full Text] [Related]
20. Cannabis, cannabidiol and tetrahydrocannabinol in sport: an overview.
Kennedy M
Intern Med J; 2022 Sep; 52(9):1471-1477. PubMed ID: 35191178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
